Literature DB >> 23694786

The effect of hepatitis B virus infection on hepcidin expression in hepatitis B patients.

Xue-hua Wang1, Pan-Pan Cheng, Fang Jiang, Xiao-Yang Jiao.   

Abstract

BACKGROUND: Hepcidin is a central regulator of iron metabolism. As hepcidin is produced mainly by hepatocytes, pathologic changes in the liver may affect hepcidin production. Abnormal hepcidin expression has been reported following liver injury, including liver cirrhosis, alcoholic liver disease, and chronic hepatitis B and hepatitis C. However, it is unclear whether there is a dose-dependent relationship between hepcidin expression and hepatitis B virus load. The aim of this study was to characterize hepcidin levels in patients with different hepatitis B virus (HBV) DNA levels.
METHODS: We investigated serum hepcidin levels in 71 patients with different HBV DNA loads, 10 patients with hepatocelluar carcinoma (HCC), and 13 healthy individuals. The relationships between hepcidin expression and hematological/liver functional parameters, iron, and inflammatory indicators were also analyzed.
RESULTS: Serum IL-6, ferritin, and hepcidin levels were significantly higher in patients with hepatitis B and in HCC patients than in controls (P<0.05), and strong positive correlations were found between hepcidin and ferritin, AST, ALT, GGT, ALP, TBIL, IBIL, and AFU, as well as between log [hepcidin] and log [HBV], respectively. There were no significant differences in hematological parameters, including WBC, Hb, and platelets among hepatitis B patients, nor was a correlation found between hepcidin and any hematological parameters.
CONCLUSION: Our results indicate that hepcidin expression is regulated by iron and inflammatory factors in hepatitis B infection patients, and that the virus load can affect hepcidin production.

Entities:  

Keywords:  Ferritin; Hepatitis B; Hepcidin; IL-6; Iron

Mesh:

Substances:

Year:  2013        PMID: 23694786

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  10 in total

Review 1.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 2.  Hepcidin and Host Defense against Infectious Diseases.

Authors:  Kathryn Michels; Elizabeta Nemeth; Tomas Ganz; Borna Mehrad
Journal:  PLoS Pathog       Date:  2015-08-20       Impact factor: 6.823

3.  Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC.

Authors:  Yanyan Wei; Wei Ye; Wei Zhao
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

Review 4.  Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.

Authors:  Driton Vela
Journal:  Mol Med       Date:  2018-03-15       Impact factor: 6.354

5.  Iron metabolism disorders in patients with hepatitis B-related liver diseases.

Authors:  Yan-Hang Gao; Jing-Yun Wang; Pei-Yan Liu; Jing Sun; Xiao-Mei Wang; Rui-Hong Wu; Xiu-Ting He; Zheng-Kun Tu; Chun-Guang Wang; Hong-Qin Xu; Jun-Qi Niu
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

6.  Hepatitis B-Associated Symptomatic Iron Overload, with Complete Resolution after Nucleoside Analogue Treatment.

Authors:  Tze Tong Tey; Richard Yiu; Wei Qiang Leow
Journal:  Case Rep Gastrointest Med       Date:  2021-12-27

7.  Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay.

Authors:  Jing Wang; Ailian Dong; Gang Liu; Gregory J Anderson; Tony Y Hu; Jian Shi; Yulin Hu; Guangjun Nie
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

Review 8.  Human Antimicrobial Peptides as Therapeutics for Viral Infections.

Authors:  Aslaa Ahmed; Gavriella Siman-Tov; Grant Hall; Nishank Bhalla; Aarthi Narayanan
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048

9.  Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case report.

Authors:  Dong-Mei Zou; Dong-Dong Rong; Hong Zhao; Li Su; Wan-Ling Sun
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

10.  Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers.

Authors:  Jinhu Wang; Wang Liu; Jean C Li; Mingyi Li; Benyi Li; Runzhi Zhu
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.